SCHEDULE: Schwab Investment Management Adjusts Medifast Stake

Charles Schwab Investment Management Inc. has reported a change in its beneficial ownership of Medifast Inc. common stock, now holding 3.6% of the class.

Summary

• Charles Schwab Investment Management Inc. has filed an amendment to its Schedule 13G, reporting its beneficial ownership of Medifast Inc. common stock.
• The filing indicates that as of June 30, 2026, Charles Schwab Investment Management Inc. beneficially owns 396,996 shares of Medifast Inc. common stock.
• This represents 3.6% of the total class of securities.
• The reporting entity is identified as an investment adviser registered under the Investment Company Act of 1940.
• The shares were acquired and are held in the ordinary course of business and not for the purpose of influencing control of the issuer.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral, primarily reporting a change in beneficial ownership without indicating significant new strategic information or performance changes.

Positives

• Charles Schwab Investment Management Inc. maintains a significant stake, indicating continued interest in Medifast Inc.

Future Outlook

No specific future outlook or guidance is provided in this filing, as it pertains to beneficial ownership reporting.

Management Comments

• "By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under 240.14a-11."
• "After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct."

Industry Context

StockSavvy.ai notes that Schedule 13G filings are routine disclosures by institutional investors regarding their holdings. This filing by Charles Schwab Investment Management Inc. indicates a specific level of investment in Medifast Inc., a company operating in the health and wellness sector, but does not provide new strategic insights into Medifast's operations.

Stakeholder Impact

• Shareholders: The filing provides transparency on institutional ownership, which can be a factor in market perception and liquidity.

Key Dates

Keywords

Medifast Inc., Charles Schwab Investment Management Inc., beneficial ownership, Schedule 13G, investment adviser, common stock